期刊文献+

胆碱能通路损伤在血管性认知功能障碍中的作用 被引量:16

The role of cholinergic pathway lesions in vascular cognitive impairment
原文传递
导出
摘要 目的通过比较胆碱能通路高信号评分(CHIPS)与缺血性脑卒中患者认知功能之间的关系,探索胆碱能通路损伤在血管性认知功能障碍中的作用。方法采用MRI对住院缺血性脑卒中患者进行CHIPS评分、总体白质高信号Schelten评分,同时使用北京版蒙特利尔认知量表(MoCA)进行认知功能评估,分析影像学评分与认知评估间的相关性。结果共纳入34例研究对象[45—82岁,平均(62.2±8.8)岁],该群体CHIPS评分与MoCA得分间标准化回归系数β=-0.382,P=0.026,而Schehen评分与MoCA得分间B=-0.357,P=0.042;在视空间与执行功能、命名、注意与抽象分项评分中,CHIPS与分项评分存在相关性;Schelten评分与命名、注意和抽象评分亦存在相关性。结论胆碱能通路损伤在白质病变所致血管性认知功能障碍中起作用,其主要作用可能是影响视空间与执行功能。 Objective To investigate the relationship between white matter lesions (WML) within the cholinergic pathway and vascular cognitive impairment. Method Middle-aged and elderly stroke patients underwent brain MRI examination and Montreal Cognitive Assessment (MoCA). Cholinergic Pathways Hyperintensities Scale (CHIPS) scores and the overall WML burden by Schelten on fluid- attenuated inversion recovery MRI images were determined and compared with MoCA scores. Spearman partial rank correlation coefficients and standardized regression coefficients were calculated. Results Thirty four patients were included (mean age (62.2 ± 8.8 ) years, 45-82 years ). MoCA scores negatively correlated with WML burdens by Schelten scores ( β = - 0. 357, P = 0. 042 ) and CHIPS scores ( β = -0. 382 ,P = 0. 026 ). CHIPS scores were negatively associated with visuospatial and executive function (r = -0. 290, P =0. 048), naming function (r = - 0.486, P = 0.002), attention (r = - 0. 311, P = 0. 037 ) and abstraction ( r = - 0. 344, P = 0. 023 ). Sehelten scores were negatively associated with naming function ( r = - 0. 492, P = 0. 002) , attention ( r = - 0. 364, P = 0. 017 ) and abstraction ( r = - 0. 390, P =0. 011 ). Conclusion WML lesions within the cholinergie pathyway play a possible role in vascular cognitive impairment especially in visuospatial and executive function.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2010年第9期612-616,共5页 Chinese Journal of Neurology
关键词 胆碱能纤维 神经通路 脑缺血 卒中 认知障碍 疾病严重程度指数 Cholinergic fibers Neurol pathways Brain ischemia Stroke Congnitive disorders Severity of illness index
  • 相关文献

参考文献15

  • 1Selden NR,Gitelman DR,Salamon-Murayama N,et al.Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain.Brain,1998,121:2249-2257.
  • 2Mesulam MM,Geula C.Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain:observations based on the distribution of acetylcholinesterase and choline acetyltransferase.J Comp Neurol,1988,275:216-240.
  • 3Bocti C,Swartz RH,Gao FQ,et al.A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.Stroke,2005,36:2126-2131.
  • 4Behl P,Bocti C,Swartz RH,et al.Strategic subconical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.Arch Neurol,2007,64:266-272.
  • 5Bohnen NI,Müler ML,Kuwabara H,et al.Age-associated leukoaraiosis and cortical cholinergic deafferentation.Neurology,2009,72:1411-1416.
  • 6Guo QH,Cao XY,Zhou Y,et al.Application study of quick cohnitive screening test in identifying mild cognitive impairment.Neurosci Bull,2010,26:47-57.
  • 7Fazekas F,Chawluk JB,Alavi A,et al.MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.AJR Am J Roentgenol,1987,149:351-356.
  • 8Scheltens P,Barkhof F,Leys D,et al.A semiquantitive rating scale for the assessment of signal hyperintensities on magnetic resonance imaging.J Neurol Sci,1993,114:7-12.
  • 9Lanctot KL,Herrmann N,Yau KK,et al.Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease:a meta-analysis.CMAJ,2003,169:557-564.
  • 10Fukui T,Hieda S,Bocti C.Do lesions involving the cortical cholinergic pathways help or hinder efficacy of donepezil in patients with Alzheimer's disease? Dement Geriatr Cogn Disord,2006,22:421-431.

二级参考文献19

  • 1贾建平.重视血管性认知障碍的早期诊断和干预[J].中华神经科杂志,2005,38(1):4-6. 被引量:265
  • 2郭起浩,孙一忞,袁晶,洪震,吕传真.8种执行功能测验在上海社区老年人中的应用[J].中国行为医学科学,2007,16(7):628-631. 被引量:32
  • 3O' Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol, 2003, 2 : 89-98.
  • 4Erkinjuntti T, Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl, 2000, 59:23-30.
  • 5Sachdev PS, Brodaty H, Valenzuela MJ, et al. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology, 2004, 62: 912-919.
  • 6Miyake A, Friedman NP, Emerson M J, et al. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cogn Psychol, 2000, 41 : 49-100.
  • 7Lezak MD, Howieson DB, Loring DW. Neuropsychological assessment. 4th ed. New York: Oxford University Press, 2004: 637-638.
  • 8Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke, 2006, 37 : 2220-2241.
  • 9Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology, 1993, 43 : 250-260.
  • 10Banich MT. Cognitive neuroscience and neuropsychology. 2nd ed. Boston: Houghton Mifflin Company, 20(M: 365-392.

共引文献13

同被引文献217

引证文献16

二级引证文献109

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部